The serotonergic agent m-chlorophenylpiperazine induces migraine attacks: A controlled study

M. Leone, A. Attanasio, D. Croci, G. Filippini, D. D'Amico, L. Grazzi, A. Nespolo, Gennaro Bussone

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

In a double-blind study versus placebo, the serotonergic agent m- chlorophenylpiperazine (mCPP) was administered to 20 healthy control subjects and 19 migraineurs to investigate the ability of mCPP (0.5 mg/kg) to induce typical migraine attacks. In the following 24-hours there were more migraines after mCPP than after placebo in both groups. These findings are consistent with involvement of 5HT(2B,2C,1A) receptor subtypes in the pathophysiology of migraine.

Original languageEnglish
Pages (from-to)136-139
Number of pages4
JournalNeurology
Volume55
Issue number1
Publication statusPublished - Jul 12 2000

Fingerprint

Serotonin Agents
Migraine Disorders
Placebos
Double-Blind Method
Healthy Volunteers
1-(3-chlorophenyl)piperazine

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

The serotonergic agent m-chlorophenylpiperazine induces migraine attacks : A controlled study. / Leone, M.; Attanasio, A.; Croci, D.; Filippini, G.; D'Amico, D.; Grazzi, L.; Nespolo, A.; Bussone, Gennaro.

In: Neurology, Vol. 55, No. 1, 12.07.2000, p. 136-139.

Research output: Contribution to journalArticle

Leone, M, Attanasio, A, Croci, D, Filippini, G, D'Amico, D, Grazzi, L, Nespolo, A & Bussone, G 2000, 'The serotonergic agent m-chlorophenylpiperazine induces migraine attacks: A controlled study', Neurology, vol. 55, no. 1, pp. 136-139.
Leone, M. ; Attanasio, A. ; Croci, D. ; Filippini, G. ; D'Amico, D. ; Grazzi, L. ; Nespolo, A. ; Bussone, Gennaro. / The serotonergic agent m-chlorophenylpiperazine induces migraine attacks : A controlled study. In: Neurology. 2000 ; Vol. 55, No. 1. pp. 136-139.
@article{3edda74bd1f245fbbcde8ced54c2df48,
title = "The serotonergic agent m-chlorophenylpiperazine induces migraine attacks: A controlled study",
abstract = "In a double-blind study versus placebo, the serotonergic agent m- chlorophenylpiperazine (mCPP) was administered to 20 healthy control subjects and 19 migraineurs to investigate the ability of mCPP (0.5 mg/kg) to induce typical migraine attacks. In the following 24-hours there were more migraines after mCPP than after placebo in both groups. These findings are consistent with involvement of 5HT(2B,2C,1A) receptor subtypes in the pathophysiology of migraine.",
author = "M. Leone and A. Attanasio and D. Croci and G. Filippini and D. D'Amico and L. Grazzi and A. Nespolo and Gennaro Bussone",
year = "2000",
month = "7",
day = "12",
language = "English",
volume = "55",
pages = "136--139",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The serotonergic agent m-chlorophenylpiperazine induces migraine attacks

T2 - A controlled study

AU - Leone, M.

AU - Attanasio, A.

AU - Croci, D.

AU - Filippini, G.

AU - D'Amico, D.

AU - Grazzi, L.

AU - Nespolo, A.

AU - Bussone, Gennaro

PY - 2000/7/12

Y1 - 2000/7/12

N2 - In a double-blind study versus placebo, the serotonergic agent m- chlorophenylpiperazine (mCPP) was administered to 20 healthy control subjects and 19 migraineurs to investigate the ability of mCPP (0.5 mg/kg) to induce typical migraine attacks. In the following 24-hours there were more migraines after mCPP than after placebo in both groups. These findings are consistent with involvement of 5HT(2B,2C,1A) receptor subtypes in the pathophysiology of migraine.

AB - In a double-blind study versus placebo, the serotonergic agent m- chlorophenylpiperazine (mCPP) was administered to 20 healthy control subjects and 19 migraineurs to investigate the ability of mCPP (0.5 mg/kg) to induce typical migraine attacks. In the following 24-hours there were more migraines after mCPP than after placebo in both groups. These findings are consistent with involvement of 5HT(2B,2C,1A) receptor subtypes in the pathophysiology of migraine.

UR - http://www.scopus.com/inward/record.url?scp=0034641334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034641334&partnerID=8YFLogxK

M3 - Article

C2 - 10891925

AN - SCOPUS:0034641334

VL - 55

SP - 136

EP - 139

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 1

ER -